Screening for Type 1 Diabetes: Role of the Diabetes Care and Education Specialist – Gary Scheiner, Susan Weiner, Davida F. Kruger, Jeremy Pettus, 2022
Early screening for pancreatic islet autoantibodies and appropriate follow-up can significantly reduce DKA risk and subsequent morbidities. Type 1 diabetes is a chronic autoimmune disease characterized by the destruction of the insulin-producing beta cells (p-cells), leading to insulin deficiency, subsequent hyperglycemia, and the need for exogenous insulin therapy. Type 1 diabetes is associated with increased m icrovascular and macrovascular disease, reduced life span, and significant healthcare-related